Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen extends PhIII sweep with more promising results for PCSK9 drug
Amgen extends PhIII sweep with more promising results for PCSK9 drug
Amgen extends PhIII sweep with more promising results for PCSK9 drug
Submitted by
admin
on January 29, 2014 - 10:27am
Source:
Fierce Biotech
News Tags:
Amgen
PCSK9 inhibitors
evolocumab
Headline:
Amgen extends PhIII sweep with more promising results for PCSK9 drug
Do Not Allow Advertisers to Use My Personal information
